Polycomb-independent activity of EZH2 in castration resistant prostate cancer

被引：0
|
作者：
Kexin Xu
Zhenhua Jeremy Wu
Anna C Groner
Housheng Hansen He
Changmeng Cai
Edward C Stack
Massimo Loda
Tao Liu
Colm Morrissey
Robert L Vessella
Philip W Kantoff
Steven P Balk
X Shirley Liu
Myles Brown
机构：
[1] Dana-Farber Cancer Institute,Center for Functional Cancer Epigenetics
[2] Dana-Farber Cancer Institute and Harvard Medical School,Department of Medical Oncology
[3] Dana-Farber Cancer Institute and Harvard School of Public Health,Department of Biostatistics and Computational Biology
[4] Beth Israel Deaconess Medical Center and Harvard Medical School,Hematology
[5] Dana-Farber Cancer Institute,Oncology Division, Department of Medicine
[6] Harvard Medical School,Center for Molecular Oncologic Pathology
[7] King’s College London,Department of Pathology, Brigham and Women’s Hospital
[8] University of Washington Medical Center,Division of Cancer Studies
[9] Puget Sound VA Health Care System,Department of Urology
来源：
Epigenetics & Chromatin | / 6卷 / Suppl 1期
关键词：
Androgen Receptor; Acute Leukemia; Castration Resistant Prostate Cancer; Histone Methyltransferase; Methyltransferase Activity;
D O I：
10.1186/1756-8935-6-S1-O14
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
    Xu, Kexin
    Wu, Zhenhua Jeremy
    Groner, Anna C.
    He, Housheng Hansen
    Cai, Changmeng
    Lis, Rosina T.
    Wu, Xiaoqiu
    Stack, Edward C.
    Loda, Massimo
    Liu, Tao
    Xu, Han
    Cato, Laura
    Thornton, James E.
    Gregory, Richard I.
    Morrissey, Colm
    Vessella, Robert L.
    Montironi, Rodolfo
    Magi-Galluzzi, Cristina
    Kantoff, Philip W.
    Balk, Steven P.
    Liu, X. Shirley
    Brown, Myles
    SCIENCE, 2012, 338 (6113) : 1465 - 1469
  • [2] Re: EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells is Polycomb-Independent Editorial Comment
    Atala, Anthony
    JOURNAL OF UROLOGY, 2013, 190 (01): : 358 - 358
  • [3] The Expression of EZH2 and Polycomb Genes in Neuroendocrine Prostate Cancer
    Shi, Mingxia
    Yang, Shu
    Khalil, Imtiaz
    Chen, Fenghua
    Yu, Xiuping
    LABORATORY INVESTIGATION, 2019, 99
  • [4] Going beyond Polycomb: EZH2 functions in prostate cancer
    Su H. Park
    Ka-Wing Fong
    Ezinne Mong
    M. Cynthia Martin
    Gary E. Schiltz
    Jindan Yu
    Oncogene, 2021, 40 : 5788 - 5798
  • [5] Going beyond Polycomb: EZH2 functions in prostate cancer
    Park, Su H.
    Fong, Ka-Wing
    Mong, Ezinne
    Martin, M. Cynthia
    Schiltz, Gary E.
    Yu, Jindan
    ONCOGENE, 2021, 40 (39) : 5788 - 5798
  • [6] The Expression of EZH2 and Polycomb Genes in Neuroendocrine Prostate Cancer
    Shi, Mingxia
    Yang, Shu
    Khalil, Imtiaz
    Chen, Fenghua
    Yu, Xiuping
    MODERN PATHOLOGY, 2019, 32
  • [7] The polycomb group protein EZH2 is involved in progression of prostate cancer
    Sooryanarayana Varambally
    Saravana M. Dhanasekaran
    Ming Zhou
    Terrence R. Barrette
    Chandan Kumar-Sinha
    Martin G. Sanda
    Debashis Ghosh
    Kenneth J. Pienta
    Richard G. A. B. Sewalt
    Arie P. Otte
    Mark A. Rubin
    Arul M. Chinnaiyan
    Nature, 2002, 419 : 624 - 629
  • [8] The polycomb group protein EZH2 is involved in progression of prostate cancer
    Varambally, S
    Dhanasekaran, SM
    Zhou, M
    Barrette, TR
    Kumar-Sinha, C
    Sanda, MG
    Ghosh, D
    Pienta, KJ
    Sewalt, RGAB
    Otte, AP
    Rubin, MA
    Chinnaiyan, AM
    NATURE, 2002, 419 (6907) : 624 - 629
  • [9] The EZH2 polycomb transcriptional repressor - a marker or mover of metastatic prostate cancer?
    Sellers, WR
    Loda, M
    CANCER CELL, 2002, 2 (05) : 349 - 350
  • [10] Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer
    Shankar, Eswar
    Franco, Daniel
    Iqbal, Omair
    Moreton, Stephen
    Kanwal, Rajnee
    Gupta, Sanjay
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 404
12345